ITP
Iron Triangle Partners Portfolio holdings
AUM
$632M
This Quarter Return
+6.33%
1 Year Return
+26.53%
3 Year Return
+134.07%
5 Year Return
+312.1%
10 Year Return
–
AUM
$693M
AUM Growth
+$693M
(+24%)
Cap. Flow
+$113M
Cap. Flow
% of AUM
16.33%
Top 10 Holdings %
Top 10 Hldgs %
57.68%
Holding
38
New
12
Increased
10
Reduced
5
Closed
11
Top Buys
| 1 |
AbbVie
ABBV
|
$51M |
| 2 |
UnitedHealth
UNH
|
$37.8M |
| 3 |
Evolent Health
EVH
|
$32.5M |
| 4 |
Sanofi
SNY
|
$28.8M |
| 5 |
DexCom
DXCM
|
$25.6M |
Top Sells
| 1 |
Universal Health Services
UHS
|
$42.3M |
| 2 |
Repligen
RGEN
|
$30.1M |
| 3 |
Boston Scientific
BSX
|
$27.8M |
| 4 |
United Therapeutics
UTHR
|
$19.9M |
| 5 |
Cigna
CI
|
$19.9M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Sanofi
SNY
$121B
| $64.2M | 9.26% | 1,179,736 +529,736 | +81% | +$28.8M |
|
|
2
AbbVie
ABBV
$372B
| $51M | 7.36% | +320,000 | New | +$51M |
|
3
Icon
ICLR
$13.8B
| $40.6M | 5.85% | 190,000 -35,000 | -16% | -$7.48M |
|
|
4
DexCom
DXCM
$29.5B
| $39.5M | 5.7% | 340,000 +219,920 | +183% | +$25.6M |
|
|
5
UnitedHealth
UNH
$281B
| $37.8M | 5.45% | +80,000 | New | +$37.8M |
|
6
Acadia Healthcare
ACHC
$2.12B
| $37M | 5.34% | 512,706 +312,706 | +156% | +$22.6M |
|
7
Gilead Sciences
GILD
$140B
| $34.8M | 5.03% | 420,000 +46,431 | +12% | +$3.85M |
|
|
8
Evolent Health
EVH
$1.12B
| $32.5M | 4.68% | +1,000,402 | New | +$32.5M |
|
9
Cooper Companies
COO
$13.4B
| $31.7M | 4.58% | 85,000 -38,000 | -31% | -$14.2M |
|
10
Intuitive Surgical
ISRG
$170B
| $30.7M | 4.42% | 120,000 +50,000 | +71% | +$12.8M |
|
11
Establishment Labs
ESTA
$1.2B
| $28.8M | 4.15% | 425,000 +17,926 | +4% | +$1.21M |
|
12
Surgery Partners
SGRY
$2.91B
| $28.1M | 4.06% | 815,552 -464,448 | -36% | -$16M |
|
13
Pacific Biosciences
PACB
$393M
| $26.6M | 3.84% | 2,300,000 +600,000 | +35% | +$6.95M |
|
14
Charles River Laboratories
CRL
$8.04B
| $26.2M | 3.78% | 130,000 -70,000 | -35% | -$14.1M |
|
15
Idexx Laboratories
IDXX
$51.8B
| $25M | 3.61% | +50,000 | New | +$25M |
|
16
Legend Biotech
LEGN
$6.41B
| $24.1M | 3.48% | +500,000 | New | +$24.1M |
|
17
Sarepta Therapeutics
SRPT
$1.78B
| $22.1M | 3.18% | 160,000 +52,251 | +48% | +$7.2M |
|
18
10x Genomics
TXG
$1.74B
| $19.5M | 2.82% | +350,000 | New | +$19.5M |
|
19
Inspire Medical Systems
INSP
$2.77B
| $16.4M | 2.36% | 70,000 -10,000 | -13% | -$2.34M |
|
20
Schrodinger
SDGR
$1.44B
| $15.7M | 2.26% | +595,697 | New | +$15.7M |
|
|
CUTR
21
DELISTED
Cutera, Inc.
CUTR
| $14.2M | 2.04% | +600,000 | New | +$14.2M |
|
22
908 Devices
MASS
$226M
| $9.03M | 1.3% | 1,050,000 +175,269 | +20% | +$1.51M |
|
|
OLK
23
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $9.01M | 1.3% | +400,000 | New | +$9.01M |
|
|
TSVT
24
DELISTED
2seventy bio
TSVT
| $8.86M | 1.28% | +868,939 | New | +$8.86M |
|
|
SWTX
25
DELISTED
SpringWorks Therapeutics
SWTX
| $8.05M | 1.16% | +312,664 | New | +$8.05M |
|